SENSORA™ Platform

Don't Miss a Beat

The SENSORA™ Cardiac Disease Detection Platform helps detect valvular heart disease earlier for improved patient outcomes.

Request Demo

The future of heart disease detection is here. SENSORA™ helps clinicians detect murmurs indicative of structural heart disease in seconds, using a familiar clinical tool — the stethoscope.

Without SENSORA™ only 43% of structural murmurs are detected.1
With SENSORA™ 90% of structural murmurs are detected.2
SENSORA™ more than doubles structural murmur detection sensitivity.1,2

Improve Outcomes With SENSORA™

Improve Outcomes With SENSORA™
AI-Powered Detection

SENSORA™ helps clinicians identify disease earlier by pairing digital stethoscopes with intelligent software that has analyzed over 1 million unique heart sounds.

Seamless Integration

SENSORA™ fits seamlessly into your clinical workflow, pairing a familiar clinical tool with automated structural murmur detection.

Downstream Optimization

SENSORA™ Care Pathway Analytics assists with critical decision-making by identifying care gaps within the patient’s journey. With your data, we provide actionable insights to improve operational efficiencies, quality metrics, patient experience, and outcomes.

SENSORA™ Overview

Digital Stethoscope
Digital Stethoscope
3M™ Littmann® CORE Digital Stethoscope
AI Murmur Detection
AI Murmur Detection
Point-of-Care Application
Care Pathway Analytics
Care Pathway Analytics
Centralized Data Accessibility

How SENSORA™ Works

Eko is invested in the early detection of cardiovascular disease. Stay tuned for more information on our de novo submission for the low EF algorithm to detect heart failure.

Schedule a Demo

CORE for Form

SENSORA™ Murmur Detection is available only in the US.

(1) Gardezi et al. Cardiac auscultation in diagnosing valvular heart disease: a comparison between general practitioners and cardiologists. European Heart Journal, Vol. 38 (2017): 11552.
(2) Eko Murmur Analysis Software User Manual, LBL 295 Rev B. Structural murmur identification in adult patients (>18 years old)